Ilimaquinone has been reported to potentiate TNF-related apoptosis-inducing ligand (TRAIL)-mediated apoptosis through upregulation of death receptor 4 and 5 in colon cancer cells [11]. The gene discussed is TNFRSF10A; the disease is colonic neoplasm.